Novel treatment paradigms for metastatic uveal melanoma
- PMID: 36456705
- PMCID: PMC9750862
- DOI: 10.1038/s41417-022-00558-y
Novel treatment paradigms for metastatic uveal melanoma
Conflict of interest statement
SK is Chief Medical Officer of TriSalus Life Sciences and SP is a member of the TriSalus Life Sciences Scientific Advisory Board.
References
-
- Jones NM, Yang H, Zhang Q, Morales-Tirado VM, Grossniklaus HE. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma. BMC Cancer. 2019;19:484. doi: 10.1186/s12885-019-5712-3. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical